Patients with T2DM have an excessive threat of atherosclerotic cardiovascular disease, it is important to prevent cardiovascular complications through the management of hypertension, dyslipidemia, and C-reactive proteins (an inflammatory marker) [71]. The gene discussed is CRP; the disease is metabolic syndrome.